Biomarkers for Myocarditis and Inflammatory Cardiomyopathy
Abhilash Suresh1, Pieter Martens2, W H Wilson Tang3,4
1Cleveland Clinic, Cleveland, OH, USA.
Insights
New biomarkers offer hope for early myocarditis diagnosis. This research reviews promising candidates to improve patient outcomes and understand the disease better.
Area of Science:
- Cardiology
- Biomarker Research
- Inflammatory Diseases
Background:
- Myocarditis involves heart inflammation, potentially leading to severe conditions like heart failure.
- Causes include autoimmune, drug-induced, and infectious agents, all resulting in myocardial damage and fibrosis.
- Current diagnostic methods are invasive and often delayed.
Purpose of the Study:
- To review recent advancements in myocarditis biomarkers.
- To identify promising candidates for early diagnosis and prognosis.
- To explore how biomarkers can improve patient outcomes.
Main Methods:
- Literature review of recent studies on myocarditis biomarkers.
- Analysis of diagnostic accuracy and prognostic value of identified biomarkers.
- Synthesis of findings to highlight key candidates.
Main Results:
- Several novel biomarkers show potential for diagnosing myocarditis.
- Biomarkers can aid in predicting disease progression and patient outcomes.
- Early detection through biomarkers may enable timely intervention.
Conclusions:
- Biomarkers are crucial for overcoming limitations of current myocarditis diagnostics.
- Promising biomarkers could revolutionize early screening and treatment strategies.
- Further research is needed to validate and implement these biomarkers in clinical practice.
Purpose Of Review:
Myocarditis is a disease caused by inflammation of the heart that can progress to dilated cardiomyopathy, heart failure, and eventually death in many patients. Several etiologies are implicated in the development of myocarditis including autoimmune, drug-induced, infectious, and others. All causes lead to inflammation which causes damage to the myocardium followed by remodeling and fibrosis. This review aims to summarize recent findings in biomarkers for myocarditis and highlight the most promising candidates.
Recent Findings:
Current methods of diagnosing myocarditis, including imaging and endomyocardial biopsy, are invasive, expensive, and often not done early enough to affect progression. Research is being done to find biomarkers of myocarditis that are cost-effective, accurate, and prognostically informative. These biomarkers would allow for earlier screening for myocarditis, as well as earlier treatment, and a better understanding of the disease course for specific patients. Early diagnosis of myocarditis with biomarkers may allow for prompt treatment to improve outcomes in patients.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:21Myocarditis I: Introduction
01:14Myocarditis III: Medical Management
01:19Pericarditis II: Clinical Features and Diagnostic Tests